“弥散性血管内凝血：当前认识与未来展望”特刊
Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives".
作者信息
Yamakawa Kazuma
机构信息
Department of Emergency and Critical Care Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, Japan.
出版信息
J Clin Med. 2022 Jun 9;11(12):3315. doi: 10.3390/jcm11123315.
Abstract
Disseminated intravascular coagulation (DIC) is characterized by the systemic activation of blood coagulation that generates and deposits fibrin that causes microvascular thrombi to develop in various organs, which contributes to multiple organ dysfunction [...].
摘要
弥散性血管内凝血（DIC）的特征是血液凝固系统被全身性激活，生成并沉积纤维蛋白，导致各器官形成微血管血栓，进而引发多器官功能障碍[...]。
相似文献
1
Special Issue on "Disseminated Intravascular Coagulation: Current Understanding and Future Perspectives".“弥散性血管内凝血：当前认识与未来展望”特刊
J Clin Med. 2022 Jun 9;11(12):3315. doi: 10.3390/jcm11123315.
2
Coagulofibrinolytic changes in patients with disseminated intravascular coagulation associated with post-cardiac arrest syndrome--fibrinolytic shutdown and insufficient activation of fibrinolysis lead to organ dysfunction.弥散性血管内凝血相关心搏骤停后综合征患者的凝血-纤溶变化——纤溶抑制和纤溶激活不足导致器官功能障碍。
Thromb Res. 2013 Jul;132(1):e64-9. doi: 10.1016/j.thromres.2013.05.010. Epub 2013 May 30.
3
Novel approaches to the management of disseminated intravascular coagulation.弥散性血管内凝血管理的新方法。
Crit Care Med. 2000 Sep;28(9 Suppl):S20-4. doi: 10.1097/00003246-200009001-00005.
4
Disseminated Intravascular Coagulation.弥散性血管内凝血
Am J Clin Pathol. 2016 Dec;146(6):670-680. doi: 10.1093/ajcp/aqw195. Epub 2016 Dec 24.
5
Microvascular thrombosis and multiple organ dysfunction syndrome.微血管血栓形成与多器官功能障碍综合征。
Crit Care Med. 2010 Feb;38(2 Suppl):S35-42. doi: 10.1097/CCM.0b013e3181c9e31d.
6
Microvascular coagulopathy and disseminated intravascular coagulation.微血管病性凝血病与弥散性血管内凝血
Crit Care Med. 2001 Jul;29(7 Suppl):S95-7; discussion S97-8. doi: 10.1097/00003246-200107001-00030.
7
Disseminated intravascular coagulation in trauma patients.创伤患者的弥散性血管内凝血
Semin Thromb Hemost. 2001 Dec;27(6):585-92. doi: 10.1055/s-2001-18864.
8
A short contemporary history of disseminated intravascular coagulation.弥散性血管内凝血的简短当代史。
Semin Thromb Hemost. 2014 Nov;40(8):874-80. doi: 10.1055/s-0034-1395155. Epub 2014 Nov 6.
9
Plasma and plasma components in the management of disseminated intravascular coagulation.血浆及血浆成分在弥散性血管内凝血治疗中的应用
Best Pract Res Clin Haematol. 2006;19(1):127-42. doi: 10.1016/j.beha.2005.01.027.
10
Advances in the understanding of the pathogenetic pathways of disseminated intravascular coagulation result in more insight in the clinical picture and better management strategies.对弥散性血管内凝血发病机制认识的进展，使人们对其临床表现有了更深入的了解，并产生了更好的管理策略。
Semin Thromb Hemost. 2001 Dec;27(6):569-75. doi: 10.1055/s-2001-18862.
引用本文的文献
1
A Narrative Review of Scoring Methods in Disseminated Intravascular Coagulation: Evaluating Diagnostic Accuracy and Clinical Utility.弥散性血管内凝血评分方法的叙述性综述：评估诊断准确性和临床实用性
Cureus. 2024 Aug 17;16(8):e67052. doi: 10.7759/cureus.67052. eCollection 2024 Aug.
2
Development and validation of a nomogram to predict mortality of patients with DIC in ICU.用于预测ICU中弥散性血管内凝血患者死亡率的列线图的开发与验证
Front Med (Lausanne). 2024 Jul 9;11:1425799. doi: 10.3389/fmed.2024.1425799. eCollection 2024.
本文引用的文献
1
Japanese rapid/living recommendations on drug management for COVID-19: updated guidelines (September 2021).日本关于新型冠状病毒肺炎药物管理的快速/现行建议：更新指南（2021年9月）
Acute Med Surg. 2021 Nov 16;8(1):e706. doi: 10.1002/ams2.706. eCollection 2021 Jan-Dec.
2
Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.新冠肺炎危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):777-789. doi: 10.1056/NEJMoa2103417. Epub 2021 Aug 4.
3
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.COVID-19 非危重症患者的肝素治疗性抗凝。
N Engl J Med. 2021 Aug 26;385(9):790-802. doi: 10.1056/NEJMoa2105911. Epub 2021 Aug 4.
4
Role of Thromboelastography as an Early Predictor of Disseminated Intravascular Coagulation in Patients with Septic Shock.血栓弹力图作为脓毒性休克患者弥散性血管内凝血早期预测指标的作用
J Clin Med. 2020 Nov 29;9(12):3883. doi: 10.3390/jcm9123883.
5
Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants.心房颤动患者缺血性卒中的病因及抗凝治疗
J Clin Med. 2020 Sep 11;9(9):2938. doi: 10.3390/jcm9092938.
6
Hematological Phenotype of COVID-19-Induced Coagulopathy: Far from Typical Sepsis-Induced Coagulopathy.新冠病毒感染所致凝血病的血液学表型：与典型脓毒症所致凝血病大不相同。
J Clin Med. 2020 Sep 5;9(9):2875. doi: 10.3390/jcm9092875.
7
Disseminated Intravascular Coagulopathy Is Associated with the Outcome of Persistent Inflammation, Immunosuppression and Catabolism Syndrome.弥散性血管内凝血与持续性炎症、免疫抑制和分解代谢综合征的预后相关。
J Clin Med. 2020 Aug 17;9(8):2662. doi: 10.3390/jcm9082662.
8
Nafamostat Mesylate Improved Survival Outcomes of Sepsis Patients Who Underwent Blood Purification: A Nationwide Registry Study in Japan.甲磺酸萘莫司他改善接受血液净化的脓毒症患者的生存结局：一项日本全国性登记研究
J Clin Med. 2020 Aug 13;9(8):2629. doi: 10.3390/jcm9082629.
9
Comparative Analysis of Three Machine-Learning Techniques and Conventional Techniques for Predicting Sepsis-Induced Coagulopathy Progression.三种机器学习技术与传统技术对脓毒症诱导的凝血病进展预测的比较分析
J Clin Med. 2020 Jul 4;9(7):2113. doi: 10.3390/jcm9072113.
10
A Systematic Summary of Systematic Reviews on Anticoagulant Therapy in Sepsis.脓毒症抗凝治疗系统评价的系统总结
J Clin Med. 2019 Nov 4;8(11):1869. doi: 10.3390/jcm8111869.
Zotero 插件